Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IMVT

Immunovant Inc

May 29 • 04:00PM ET

33.30

-0.20 -0.60 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KYMR BMRN MDGL RYTM APGE KRYS NUVL VKTX AXSM NBIX

| Held by: XBI VTI IWM VB VBK VXF IWO IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.77	Insider Own	60.57%	Shs Outstand	203.94M	Perf Week	-2.43%
Market Cap	6.84B	Forward P/E	-	EPS next Y	-2.54	Insider Trans	15.09%	Shs Float	80.96M	Perf Month	23.56%
Enterprise Value	5.93B	PEG	-	EPS next Q	-0.60	Inst Own	51.84%	Short Float	25.16%	Perf Quarter	20.09%
Income	-505.61M	P/S	-	EPS this Y	5.50%	Inst Trans	0.68%	Short Ratio	11.40	Perf Half Y	39.04%
Sales	0.00M	P/B	7.97	EPS next Y	3.09%	ROA	-58.29%	Short Interest	20.37M	Perf YTD	31.00%
Book/sh	4.18	P/C	7.58	EPS next 5Y	18.99%	ROE	-64.82%	52W High	36.28 -8.23%	Perf Year	123.64%
Cash/sh	4.39	P/FCF	-	EPS past 3/5Y	-17.37% -17.75%	ROIC	-59.30%	52W Low	14.09 136.34%	Perf 3Y	58.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.67% 5.79%	Perf 5Y	119.66%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-1.22%	Oper. Margin	-	ATR (14)	1.90	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.09	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	62.82	Recom	1.59
Dividend Gr. 3/5Y	- -	Current Ratio	9.09	EPS Q/Q	-13.69%	SMA20	10.68%	Beta	0.76	Target Price	45.76
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	20.45%	Rel Volume	0.94	Prev Close	33.50
Employees	315	LT Debt/Eq	0.00	Earnings	May 20 BMO	SMA200	41.69%	Avg Volume	1.79M	Price	33.30
IPO	Jun 21, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.31% -	Trades		Volume	1,684,589	Change	-0.60%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)